Two great examples are Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) and Vertex Pharmaceuticals (NASDAQ: VRTX). Warren ...

With a better upfront offer on the table, enough bluebird bio investors have tendered their shares for the company's sale to ...

KJ Muldoon came into the world with a genetic time bomb ticking inside him.

Beam Therapeutics faces slow pipeline progress and high R&D costs despite a $500M cash boost. Learn why patience is key for ...

Cell and gene therapy (C&GT) is set to revolutionise treatment of complex diseases, offering new possibilities for patients.

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Aligning with EU on genetically modified food and agricultural products will create a regulatory cliffedge for a sector which ...

The death of a patient in a trial of an experimental gene therapy casts new shadows over a technology once seen as the future ...

Two groundbreaking biotechnology advances are fundamentally altering human health and food production in 2025, moving from ...

Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...

Novo Nordisk has doubled down on position in the sickle cell disease (SCD ... a group of disorders that includes SCD and beta thalassaemia and result from abnormal production or structure of ...

How to redeem and use Fazbear World Tower Defense codes How to get more Fazbear World Tower Defense codes Why can’t I redeem my codes? How to get more free rewards in Fazbear World Tower Defense ...